Showing results (1261-1270 of 1,585) with videos related to

Sort By:
Pageof 159
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Synthesis of novel antimitotic agents based on 2-amino-3-aroyl-5-(hetero)arylethynyl thiophene derivativesRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 11, 2008
Synthesis and biological evaluation of 2-aroyl-4-phenyl-5-hydroxybenzofurans as a new class of antitubulin agentsRomeo Romagnoli, Pier Giovanni Baraldi, Taradas Sarkar, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 12, 2018
Diffusion-weighted imaging and loco-regional N staging of patients with colorectal liver metastasesCristiana Bonifacio, Luca Viganò, Paolo Felisaz, et al.
The Journal of Antimicrobial Chemotherapy|May 4, 2013
Inhibition of infection and transmission of HIV-1 and lack of significant impact on the vaginal commensal lactobacilli by carbohydrate-binding agentsMariya I Petrova, Leen Mathys, Sarah Lebeer, et al.
Bioorganic & Medicinal Chemistry|September 24, 2013
Towards new C6-rigid S-DABO HIV-1 reverse transcriptase inhibitors: synthesis, biological investigation and molecular modeling studiesHai-Qiu Wu, Zi-Hong Yan, Wen-Xue Chen, et al.
Minerva Urology and Nephrology|February 11, 2022
The fight between PCNL, laparoscopic and robotic pyelolithotomy: do we have a winner? A systematic review and meta-analysisGuglielmo Mantica, Federica Balzarini, Francesco Chierigo, et al.
Central European Journal of Urology|November 3, 2021
Bladder cancer histological variants: which parameters could predict the concordance between transurethral resection of bladder tumor and radical cystectomy specimens?Guglielmo Mantica, Stefano Tappero, Stefano Parodi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1993
Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitorsJ Balzarini, A Karlsson, A M Vandamme, et al.
Cancer|July 15, 1993
Current role of gallium scan and magnetic resonance imaging in the management of mediastinal Hodgkin lymphomaM D Gasparini, L Balzarini, M R Castellani, et al.
Antiviral Research|December 1, 1990
2'-Azido-2',3'-dideoxythymidine: synthesis and crystal structure of a 2'-substituted dideoxynucleosideA Van Aerschot, D Everaert, G Gosselin, et al.
Pageof 159